|
|||||
|
|
| 治疗性单克隆抗体研究进展 | |
| 引用本文： | 孙思凡,张部昌,靳彦文.治疗性单克隆抗体研究进展[J].生物技术通讯,2009,20(2):258-262. |
| 作者姓名： | 孙思凡 张部昌 靳彦文 |
| 作者单位： | 1. 军事医学科学院,生物工程研究所,北京,100850;安徽大学,生命科学学院,安徽,合肥,230039 2. 安徽大学,生命科学学院,安徽,合肥,230039 3. 军事医学科学院,生物工程研究所,北京,100850 |
| 摘 要： | 杂交瘤技术使鼠源单克隆抗体（鼠单抗）被广泛用于人类疾病的诊断和研究,建立了治疗性抗体的第一个里程碑。但随后出现的人抗鼠抗体等副作用极大地限制了鼠单抗的临床应用。随着生物学技术的发展和抗体基因结构的阐明,应用DNA重组技术和抗体库技术对鼠单抗进行人源化改造,先后出现了嵌合抗体、改型抗体和全人抗体,同时也涌现了各种单抗衍生物,它们从不同角度克服了鼠单抗临床应用的不足,未人类疾病治疗带来新的曙光。我们就上述治疗性抗体人源化的研究进展做简要综述。 |
| 关 键 词： | 单克隆抗体 治疗性抗体 抗体人源化 |
Advances on Therapeutic Monoclonal Antibody |
|
| SUN Si-fan,ZHANG Bu-Chang,JIN Yan-Wen.Advances on Therapeutic Monoclonal Antibody[J].Letters in Biotechnology,2009,20(2):258-262. | |
| Authors: | SUN Si-fan ZHANG Bu-Chang JIN Yan-Wen |
| Institution: | 1. Beijing Institute of Biotechnology, Beijing 100850; 2. College of Life Science, Anhui University, Hefei 230039; China) |
| Abstract: | Hybridom techniques have made mouse monoclonal antibody widely use in diagnosis and research of human disease, and established the first milestone of therapeutic antibody. But subsequent side effects such as HAMA response greatly limits the clinical application of mouse antibody. With the biology development and antibody genetic structure clarification, people can humanize mouse antibody with DNA recombination and antibody library which developed antibody techniques from chimeric and reshaped to human antibody, and now variety of monoclonal antibody derivatives. Both hu- manized monoclonal antibody and its derivative overcome the clinical shortage of mouse antibody from different angles, also bring a new dawn to human disease. In this text, we summarized the progress on the humanization of therapeutic antibody. |
| Keywords: | monoclonal antibody therapeutic antibody humanized antibody |
| 本文献已被 维普 万方数据 等数据库收录！ | |